ABSTRACT
INTRODUCTION Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world (1,2). There are two forms of advanced AMD: central geographic atrophy and neovascular AMD. While new treatments have shown improved outcomes for patients with neovascular AMD over the last decade, there remains no proven treatment for central geographic atrophy. Therapies that focus on prevention by addressing modifi able risk factors such as diet and nutritional status are key approaches to reducing the burden of disease. Such preventive strategies are especially important as life expectancy in the United States and Europe continues to increase.
